Prof. Jakob Zinsstag

Veterinary Epidemiology

EBVS® European Specialist in Veterinary Public Health - Population Medicine

Jakob Zinsstag graduated with a doctorate in veterinary medicine (Dr. med. vet.) on Salmonella diagnosis at the Veterinary Faculty of the University of Berne in 1986. After his studies he worked in rural practice and as post doctoral fellow on trypanosomiasis research at the Swiss Tropical Institute. From 1990 to end of 1993 he led a livestock helminthosis project for the University of Berne at the International Trypanotolerance Centre in The Gambia. From 1994 to 1998 he directed the Centre Suisse de Recherches Scientifiques in Abidjan, Côte d’Ivoire. Since 1998 he leads a research group at the Swiss Tropical and Public Health Institute (Swiss TPH) in Basel on the interface of human and animal health with a focus on health of nomadic people and control of zoonoses in developing countries under the paradigm of “one health”. He holds a PhD in Tropical Animal Production from the Prince Leopold Institute of Tropical Medicine of Antwerp, Belgium. Since 2010 he is Professor of Epidemiology at the University of Basel and since 2011 deputy head of department of Epidemiology and Public Health at the Swiss TPH . He is a diplomate of the European College of Veterinary Public Health (ECVPH) and member of the scientific advisory board of the Prince Leopold Institute of Tropical Medicine of Antwerp, Belgium. He is a member of the transdisciplinarity board of the Swiss Academies of Sciences ( and president of the International Association of Ecology and Health (
The research group is currently part several larger international networks. The EU FP7 funded network on Integrated Control of Zoonoses in Africa (ICONZ ) and the Wellcome Trust funded Africa Capacity Building network (AfriqueOne The group's projects are located in Chad, Mali, Mauritania, Côte d’Ivoire, Ethiopia, Tanzania, Viet Nam, Kyrgyzstan and Mongolia and the group is networking with research institutes and veterinary authorities in these countries and England, France, Belgium, Canada and the USA.